Page last updated: 2024-09-05

farglitazar and pituitrin

farglitazar has been researched along with pituitrin in 1 studies

Compound Research Comparison

Studies (farglitazar)	Trials (farglitazar)	Recent Studies (post-2010) (farglitazar)	Studies (pituitrin)	Trials (pituitrin)	Recent Studies (post-2010) (pituitrin)
35	3	5	22,137	594	2,101

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashton, TT; Baines, D; Bisi, J; Blazer-Yost, BL; Brown, KK; Harrington, W; Kalsi, K; Maurio, FP; Murray, D; Nofziger, C; Smith, CD; West, TA	1

Other Studies

1 other study(ies) available for farglitazar and pituitrin

Article	Year
PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line. American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1 Topics: Animals; Biological Transport; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dogs; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Kidney; Ligands; Models, Animal; Oxazoles; Pioglitazone; PPAR gamma; RNA, Messenger; Signal Transduction; Thiazolidinediones; Tyrosine; Vasopressins	2009

Article

Year

PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line.

American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1

Topics: Animals; Biological Transport; Cell Line; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dogs; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Kidney; Ligands; Models, Animal; Oxazoles; Pioglitazone; PPAR gamma; RNA, Messenger; Signal Transduction; Thiazolidinediones; Tyrosine; Vasopressins

2009